MagVenture USA banner
< Back
You are here » US Customers

Regulations in the USA

In the USA federal law regulates the sale of Medical Devices through the US Food and Drug Administration (FDA). This is done to ensure safety and effectiveness. Devices which are permitted to be marketed for their intended use must either have a 510(k) or PMA clearance.

MagPro® stimulators R20, R30, R30 with MagOption, X100, and X100 with MagOption are all FDA 510(k) cleared (k160280, k061645, k091940 and k150641).

k150641: The intended use is treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.

k160280, k061645, k091940: The intented use is for stimulation of peripheral nerves for diagnostic purposes. 

The use of devices for other than their FDA cleared intended use is considered as investigational. Such use is only permitted if the Investigational Device Exemption (IDE) guidelines have been followed. For full information on this procedure, please consult FDA's website (www.fda.gov). 

All investigational devices must be labeled in accordance with the labeling provisions of the IDE regulation (§ 812.5) and must bear a label with this statement: 

"CAUTION Investigational Device. Limited by Federal (or United States) law to investigational use."

Please note that transcranial magnetic stimulation ( TMS, rTMS) with MagPro stimulators is considered investigational in the USA (except the above cleared intended use). For further information please contact MagVenture

MagVenture Inc.
2300 Lakeview Parkway, 
Suite 700
Alpharetta, GA 30009

Phone: +1 888-MAGPRO-4 
(+1 888-624-7764)
Fax: +1 678-809-1415

Email: infousa@magventure.com